Total revenues
 |
$4.8 billion
 |
$4.5 billion
 |
8%
 |

Operating earnings*
|
$308.8 million |
$315.9 million |
(2)% |
|
Net income
|
$365.8 million |
$330.0 million |
11% |
|
Per share results:
|
|
|
|
|
Operating earnings*
|
$1.92 |
$2.03 |
|
|
Favorable development of prior-period health care cost estimates
|
(0.17) |
(0.69) |
|
|
Operating earnings, excluding development*
|
$1.75 |
$1.34 |
31% |
|
Income from continuing operations
|
$2.03 |
$2.12 |
|
|
Income from discontinued operations**
|
0.25 |
- - - - |
|
|
Net income |
$2.28 |
$2.12 |
8% |
* For full description of operating earnings and per share operating earnings, refer to footnote 1 at end of press release.
** Refer to footnote 3 at end of press release.
|